End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,615 MXN | +20.46% | -.--% | -.--% |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
05-07 | WACKER CHEMIE AG : Gets a Neutral rating from DZ Bank | ZD |
Sales 2024 * | 6.14B 6.66B 113B 9.07B | Sales 2025 * | 6.6B 7.16B 122B 9.76B | Capitalization | 5.06B 5.49B 93.37B 7.48B |
---|---|---|---|---|---|
Net income 2024 * | 225M 244M 4.15B 333M | Net income 2025 * | 413M 448M 7.62B 610M | EV / Sales 2024 * | 0.87 x |
Net Debt 2024 * | 251M 273M 4.64B 371M | Net Debt 2025 * | 197M 214M 3.63B 291M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
12.6
x | Employees | 16,425 |
Yield 2024 * |
2.42% | Yield 2025 * |
3.99% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 day | +20.46% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 15-10-31 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 08-05-07 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08-05-07 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08-05-07 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.05% | 19.39B | |
+5.08% | 4.19B | |
+17.49% | 1.59B | |
+2.84% | 1.31B | |
+19.82% | 959M | |
-11.55% | 688M | |
-36.36% | 566M | |
-13.97% | 290M | |
-12.92% | 252M |
- Stock Market
- Equities
- WCH Stock
- WCH N Stock